Vertex Announces Webcast of its Presentations at Two Investor Conferences
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Vertex will webcast its presentation at the Sanford C. Bernstein Strategic Decisions Conference on Wednesday, May 30, 2012 at 8:00 a.m. EDT and at the Goldman Sachs Global Healthcare Conference 2012 on Wednesday, June 6, 2012 at 1:20 p.m. PDT (4:20 p.m. EDT).
The presentations will be webcast live and may be accessed from ‘Events & Presentations’ on the home page of Vertex’s website at www.vrtx.com. A replay of the webcasts will also be available on the Company’s website for two weeks following the presentations. To ensure a timely connection, it is recommended that users register at least 15 minutes prior to the scheduled webcast.
Contacts:
Vertex Pharmaceuticals Incorporated
Michael Partridge, 617-444-6108
Vice President, Investor Relations
The presentations will be webcast live and may be accessed from ‘Events & Presentations’ on the home page of Vertex’s website at www.vrtx.com. A replay of the webcasts will also be available on the Company’s website for two weeks following the presentations. To ensure a timely connection, it is recommended that users register at least 15 minutes prior to the scheduled webcast.
About Vertex
Vertex creates new possibilities in medicine. Our team discovers, develops and commercializes innovative therapies so people with serious diseases can lead better lives.
Vertex scientists and our collaborators are working on new medicines to cure or significantly advance the treatment of hepatitis C, cystic fibrosis, rheumatoid arthritis, epilepsy and other life-threatening diseases.
Founded more than 20 years ago in Cambridge, MA, we now have ongoing worldwide research programs and sites in the U.S., U.K. and Canada. Today, Vertex has more than 2,000 employees around the world, and Sciencemagazine named Vertex number one on its 2011 list of Top Employers in the life sciences.
Vertex creates new possibilities in medicine. Our team discovers, develops and commercializes innovative therapies so people with serious diseases can lead better lives.
Vertex scientists and our collaborators are working on new medicines to cure or significantly advance the treatment of hepatitis C, cystic fibrosis, rheumatoid arthritis, epilepsy and other life-threatening diseases.
Founded more than 20 years ago in Cambridge, MA, we now have ongoing worldwide research programs and sites in the U.S., U.K. and Canada. Today, Vertex has more than 2,000 employees around the world, and Sciencemagazine named Vertex number one on its 2011 list of Top Employers in the life sciences.
Vertex’s press releases are available at www.vrtx.com.
Contacts:
Vertex Pharmaceuticals Incorporated
Michael Partridge, 617-444-6108
Vice President, Investor Relations
No comments:
Post a Comment